ReviewJNMA; journal of the Nepal Medical Association2025
Considerations on the Management of Zinc Phosphide Toxicity and Proposed Therapeutic Approaches.
Review in JNMA; journal of the Nepal Medical Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zinc phosphide (ZnP) is a rodenticide commonly used in agriculture for pest control, but it can cause acute human poisoning, through ingestion in suicide attempts. The toxicokinetics of ZnP are not well understood, although it is believed that its primary mechanism of toxicity involves the inhibition of Complex IV of Cytochrome C Oxidase, similar to aluminum phosphide (ALP) poisoning. However, there are notable differences between the two. The rarity of acute ZnP toxicity and the misconception that it mirrors ALP poisoning have hindered the development of effective treatment strategies. This review critically examines the challenges of existing treatment protocols and proposes new approaches based on current evidence. A thorough literature review on the management of ZnP and ALP poisoning was conducted. Due to the delayed onset of symptoms in ZnP poisoning, aggressive gastrointestinal decontamination is recommended prior to toxin absorption. Furthermore, the potential for acute liver failure in early ZnP cases requires targeted treatment for hepatic injury. Since systemic absorption of phosphine can produce effects similar to ALP poisoning, existing ALP treatment protocols may also aid in managing ZnP toxicity. This study proposes a treatment protocol for ZnP poisoning, emphasizing the need for further randomized trials to validate its effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.